Infectious Disease Clinical Trials

Trusted Partners in Infectious Disease Clinical Trials

At Navitas Life Sciences, we specialize in infectious disease clinical trials, bringing decades of experience and cutting-edge innovation to the study of infectious diseases. Our highly experienced team of specialists in immunology and infectious diseases designs, conducts, and manages comprehensive clinical trials. We ensure robust and adaptive trial designs, leveraging real-time analytics and advanced technologies to conduct efficient studies on infectious diseases. By maintaining a strong local presence and partnerships globally, we deliver tailored solutions for immunology clinical trials that align with regulatory requirements, enhancing trial efficiency and success rates.

Accelerating Market Reach in Infectious Disease Research

Our extensive expertise in the study of infectious diseases is complemented by our unwavering focus on quality and compliance. With over 40 GCP and non-GCP audits and inspections, and no critical findings, we adhere to the highest standards of clinical trial management. Our services span the entire trial spectrum, from Phase I to Phase IV, providing end-to-end support with regulatory insights and strategic operational oversight. Powering possibilities in immunology clinical trials and infectious disease studies to ensure superior outcomes, positioning us as a trusted partner in the fight against infectious diseases worldwide.

Highlights of our immunology clinical trial support include:

Brochure

Alt Text

Efficient Clinical Trials

Find out about our in-depth domain expertise, vast experience in managing global studies, extensive medical and scientific talent pool, best-practice driven project management and governance model, adoption and use of proven technologies, and more.

CASE STUDY

Alt Text

Adaptive design for a global Study for a First-in-Class Therapy for Critical Covid-19 Patient

Learn about end-to-end support to a US Based mid-size biotech company in the development of their first in class therapy for critically ill covid patients.

Article

Alt Text

Key Takeaways From The FDA Guidance On DCTs

Published in: The Life Science Leader
Explore some of the highlights of the guidance provided by USFDA towards DCTs.
Image
Image

Extensive Experience in Managing Efficient Infectious Diseases Clinical Trials

0
Professionals incl. Doctors, PhDs, Biostatisticians, Pharmacologists
0
Phase I-IV Clinical Trials
0
Years of Experience
0
Regulatory compliance

Gain the Navitas Life Sciences Edge

Holistic Approach

Holistic Approach

Balancing scientific rigor with cost-effectiveness.
8 Offices World Wide

8 Offices World Wide

Including 4 delivery centers across the globe.

Specialized Focus

Specialized Focus

Expertise in vulnerable populations and niche areas.
Strategic Support

Strategic Support

From TPP to regulatory compliance, we cover all bases.
Expert Team

Expert Team

Medical monitors with rich academic and industry experience.

BLOGS

Alt Text

Immunization Awareness Month 2024: Elevating Infectious Diseases and Vaccine Clinical Trials

At Navitas Life Sciences, our commitment to combating infectious diseases through rigorous clinical trials underscores our dedication to advancing global health.
Alt Text

Infectious Disease and Vaccine CRO

As a sought-after infectious disease and vaccine CRO, Navitas Life Sciences recognizes that vaccines continue to be one of the most powerful tools for disease prevention, safeguarding communities against a wide range of infectious diseases.
Alt Text

How We Increase Infectious Diseases and Vaccine Clinical Trials Success Rate

Our team of specialists in Infectious Diseases, Immunology, and Vaccine studies has extensive experience in designing and managing infectious disease clinical trials.

Get in touch

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us